Products | GSK US
Products Learn more about our product portfolio and how we’re prioritizing specialty medicines and vaccines to get ahead of disease together. Below you can find the full A-Z list of our …
Home | GSK US
Ben Schwartz, VP of Oncology, shares his 20-year GSK journey, from drug discovery to leading research. Addressing Long-Standing Barriers to Adult Immunization Our COiMMUNITY …
Oncology | GSK US
Together with GSK Oncology is here to help, offering patients and healthcare professionals a variety of access and reimbursement services for all GSK oncology products—all in one place.
Press releases | GSK US
GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227, receives US FDA Breakthrough Therapy Designation in late-line relapsed or refractory osteosarcoma Regulatory designation …
Company | GSK US
GSK has a significant footprint in the US across commercial, R&D, manufacturing, and corporate functions. We employ ~15,000 people across the US and have two corporate hubs. Explore …
Contact us - GSK
Contact us online at GSK for You. RRC - a reimbursement support program that helps patients and healthcare professionals in the US with coverage, coding and reimbursement issues for …
Therapeutic areas | GSK US
Explore innovations in medicines and healthcare from inside and outside our labs. Discover more about what we do, the people behind GSK and how we operate responsibly for all our …
HIV - GSK US
Products Products Close menu ... Trade marks are owned by or licensed to the GSK group of companies. GSK plc. Registered in England and Wales No. 3888792. Registered office: 79 …
Locations | GSK US
Products Products Close menu ... Trade marks are owned by or licensed to the GSK group of companies. GSK plc. Registered in England and Wales No. 3888792. Registered office: 79 …
Careers | GSK US
At GSK, we unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, …